Rising Adoption of Minimally Invasive Procedures Boosts Congenital Heart Defect Device Sales: A Key Driver Powering Congenital Heart Defect Devices Market Growth In 2025

The Congenital Heart Defect Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Congenital Heart Defect Devices Market Size and Its Estimated Growth Rate?
The congenital heart defect devices market is projected to grow from $2.91 billion in 2024 to $3.13 billion in 2025, at a CAGR of 7.5%. The expansion can be attributed to growing healthcare awareness campaigns, an increase in heart defect screening programs, tighter medical device regulations, a rising prevalence of congenital heart defects, and a higher risk of organ failure.

The congenital heart defect devices market is expected to reach $4.13 billion by 2029, growing at a CAGR of 7.2%. Growth is attributed to increasing clinical trials, the aging population, rising congenital heart defects, government support, and more specialized medical centers. Trends include technological advancements, digital health technologies, personalized medicine, 3D printing, and wearable devices.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18543

How Are Emerging Segments Shaping the Congenital Heart Defect Devices Market Landscape?
The congenital heart defect devices market covered in this report is segmented -

1) By Device Type: Catheters, Pacemakers, Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Leadless Pacemakers, Implantable Cardioverter Defibrillators, Biventricular Devices, Implanted Cardiac Loop Recorders, Other Device Types
2) By Defect Type: Atrial Septal Defect, Ventricular Septal Defect, Atrioventricular Septal Defect, Tricuspid Atresia, Truncus Arteriosus, Other Defect Types
3) By End user: Hospitals, Specialty Clinics, Academic And Research Institute, Other End Users

Subsegments:
1) By Catheters: Balloon Catheters, Diagnostic Catheters, Guiding Catheters
2) By Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Leadless Pacemakers
3) By Implantable Cardioverter Defibrillators: Single-Chamber Icds, Dual-Chamber Icds, Subcutaneous Icds
4) By Biventricular Devices: Crt-P (Cardiac Resynchronization Therapy Pacemakers), Crt-D (Cardiac Resynchronization Therapy Defibrillators)
5) By Implanted Cardiac Loop Recorders: Traditional Implantable Loop Recorders, Subcutaneous Implantable Loop Recorders
6) By Other Device Types: Transcatheter Heart Valves, Ventricular Assist Devices (VADS)

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18543&type=smp

Which Growth Factors Are Influencing Congenital Heart Defect Devices Market Expansion?
The rise in minimally invasive procedures is expected to stimulate the growth of the congenital heart defect device market. Minimally invasive procedures use small incisions or natural body openings to reduce trauma and enhance recovery. Advances in technology and patient preference for less invasive treatments are contributing to this rise. Congenital heart defect devices aid in diagnosing and treating heart conditions through smaller incisions or catheter-based methods. According to the American Society of Plastic Surgeons in 2022, there were 23.7 million cosmetic minimally invasive procedures performed in the U.S., a 7% increase from previous years. Therefore, the rise in minimally invasive procedures is fueling the congenital heart defect device market.

Who Are the Dominant Players Across Different Congenital Heart Defect Devices Market Segments?
Major companies operating in the congenital heart defect devices market are Pfizer Inc., Johnson & Johnson, AstraZeneca plc., Abbott Laboratories, GlaxoSmithKline plc., Medtronic plc., Philips Healthcare, Boston Scientific Corporation, W. L. Gore & Associates Inc., Masimo Corporation, Lepu Medical Technology (Beijing) Co. Ltd., MicroPort Scientific Corporation, Stereotaxis Inc., Berlin Heart GmbH, Ventracor Limited, Syncardia Systems LLC, On-X Life Technologies Inc., Occlutech Holding AG, Sahajanand Medical Technologies Pvt. Ltd., Response Biomedical Corporation, Xeltis AG, Procyrion Inc., Heartstitch Inc., Cardia Inc., OSYPKA Medical GmbH

What Congenital Heart Defect Devices Market Trends Are Gaining Traction Across Different Segments?
Companies in the congenital heart defect devices market are pursuing strategic partnerships to accelerate innovation and expand market access. For example, in May 2024, SMT (Sahajanand Medical Technologies Pvt Ltd), an India-based company, formed a partnership with HeartX, a MedTech firm, to integrate HeartX's innovative JOVE VB Stent into their offerings for improved patient care and treatment effectiveness in the cardiovascular space.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/congenital-heart-defect-devices-global-market-report

Which Geographic Regions Are Expected to Dominate the Congenital Heart Defect Devices Market in the Coming Years?
North America was the largest region in the congenital heart defect devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congenital heart defect devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Congenital Heart Defect Devices Market?
2. What is the CAGR expected in the Congenital Heart Defect Devices Market?
3. What Are the Key Innovations Transforming the Congenital Heart Defect Devices Industry?
4. Which Region Is Leading the Congenital Heart Defect Devices Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.